Researchers say identified mAbs could represent “a basis to develop a treatment that is urgently needed as measles virus ...

Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STAT ...

SAB Biotherapeutics Inc (SABS) reports significant progress in its SAB142 program despite increased R&D and G&A expenses, maintaining a strong cash position to support future growth.

FDA fast track designation enables increased regulatory interaction and potential rolling BLA review for RPTR-1.201 in ...

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, ...

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study Patients with advanced ...

We read with great interest the recent article by Tsai et al,1 which compared characteristics between primary neuromyelitis ...

Scientists just took a step toward developing a therapy that could prevent someone from getting measles after they have been ...

Scientists at La Jolla Institute for Immunology (LJI) are the first in the world to characterize human antibodies capable of ...

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's ...

Lamina I projection neurons that respond selectively to skin cooling receive monosynaptic input from Trpm8-expressing primary afferents and innervate brain regions involved in perception of cold and ...

Microsoft continued to enhance speech functionality in its Visual Studio Code editor with a new accessibility tool that lets developers dictate directly into the editor. The voice dictation feature in ...